Pixee Medical

Overview
News
Extended Reality?

France-based Pixee Medical specializes in surgical navigation tools backed by its proprietary algorithms, which allow smartphones or connected glasses to identify objects in a 3D space with millimeter precision. Key products:

1) Knee+, an AR tool aiding surgeons during knee replacement surgeries. It uses smart glasses to provide real-time 3D positioning data, analyzing specific markers on instruments. The system was commercially launched in the US in March 2022, while commercialization of the solution in Europe and Australia began in January 2021, having received 510(k) FDA clearance in April 2021.

2) Shoulder+, launched in August 2023 , is an MR tool for shoulder surgeries. The tool automatically creates a 3D model of the bone, helping surgeons plan prosthesis placement. During the procedure, the virtual model helps ensure the implant aligns with the surgical plan. The system has secured the CE marking, indicating its compliance with European Union standards and is 510(k) FDA cleared in the US.

Key customers and partnerships

In November 2022, MicroPort Orthopedics expanded its partnership with Pixee Medical for assistance in total knee arthroplasty in the US.

In February 2021, Pixee Medical and Mathys signed a non-exclusive distribution agreement for the company’s Knee+ AR navigation system. Mathys additionally promoted the solution in Europe and select countries.

Funding and financials

In February 2024, the company raised USD 15 million in venture capital funding, co-led by Relyens Innovation Santé, UI Investissement, Innovacom, and Angelor. Funds were earmarked to expedite Pixee Medical's growth within the US, with the opening of a subsidiary in the first quarter of 2024. It also planned to roll out its latest AR surgical navigation platforms in the near term, expand to Asia with an office in Singapore, and onboard new talent to bolster its growth.

HQ location:
18, rue Alain Savary Besançon FRA
Founded year:
2017
Employees:
11-50
IPO status:
Private
Total funding:
USD 15.1 mn
Last Funding:
USD 15.1 mn (Series B; Feb 2024)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...

EDGE Insights

Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.